$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Determination of Chemical Stability of Two Oral Antidiabetics, Metformin and Repaglinide in the Solid State and Solutions Using LC-UV, LC-MS, and FT-IR Methods 원문보기

Molecules a journal of synthetic chemistry and natural product chemistry, v.24 no.24, 2019년, pp.4430 -   

Gumieniczek, Anna (Department of Medicinal Chemistry, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland) ,  Berecka-Rycerz, Anna (anna.berecka@umlub.pl) ,  Mroczek, Tomasz (Department of Medicinal Chemistry, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland) ,  Wojtanowski, Krzysztof (anna.berecka@umlub.pl)

Abstract AI-Helper 아이콘AI-Helper

Firstly, metformin and repaglinide were degraded under high temperature/humidity, UV/VIS light, in different pH and oxidative conditions. Secondly, a new validated LC-UV method was examined, as to whether it validly determined these drugs in the presence of their degradation products and whether it ...

주제어

참고문헌 (45)

  1. 1. Kinaan M. Ding H. Triggle C.R. Metformin: An old drug for the treatment of diabetes but a new drug for the protection of the endothelium Med. Princ. Pract. 2015 24 401 415 10.1159/000381643 26021280 

  2. 2. Guardado-Mendoza R. Prioletta A.M. Jimenez-Ceja L.M. Sosale A. Folli F. The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus Arch. Med. Sci. 2013 9 936 943 10.5114/aoms.2013.34991 24273582 

  3. 3. FDA Guideline for Industries Impurities in Drug Product, Draft Guidance, Centre for Drug Evaluation and Research (CDER) FDA Silver Spring, MD, USA 1998 

  4. 4. International Conference on Harmonization (ICH) Guidance for Industry Q1A(R2): Stability Testing of New Drug Substances and Products International Conference on Harmonization (ICH) Geneva, Switzerland 2003 

  5. 5. Liu W. Hsu J.C. Bretz F. Hayter A.J. Han Y. Shelf-life and its estimation in drug stability studies J. Appl. Stat. 2014 41 1989 2000 10.1080/02664763.2014.898135 

  6. 6. Blessy M.N. Patel R.D. Prajapati P.N. Agrawal Y.K. Development of forced degradation and stability indicating studies of drugs―A review J. Pharm. Anal. 2014 4 159 165 10.1016/j.jpha.2013.09.003 29403878 

  7. 7. Geetha Swarupa P. Lakshmana Rao K. Prasad K.R.S. Suresh Babu K. Development and validation of stability indicating reversed phase high-pressure liquid chromatography method for simultaneous estimation of metformin and empagliflozin in bulk and tablet dosage form Asian J. Pharm. Clin. Res. 2016 9 126 135 

  8. 8. Runja C. Ravikumar P. Avanapu S.R. Stability indicating RP-HPLC method for simultaneous estimation of alogliptin benzoate and metformin hydrochloride in tablet dosage form Int. J. Pharm. Pharm. Sci. 2016 8 116 120 

  9. 9. Vaingankar P.N. Amin P.D. Development and validation of stability-indicating RP-HPLC method for simultaneous determination of metformin HCl and glimepiride in fixed-dose combination Anal. Chem. Insights 2016 2016 13 20 

  10. 10. Mohamed Y.A.S. Mohamed A.M.I. Mohamed F.A.F. Ahmed S.A. New salting out stability-indicating and kinetic thin layer chromatographic method for determination of glimepiride and metformin HCl binary mixture J. Chromatogr. Sci. 2015 53 1603 1610 10.1093/chromsci/bmv057 26006135 

  11. 11. Mohammad Y. Gowri S.D. A validated stability indicating high-performance liquid chromatographic method for simultaneous determination of metformin HCl and dapagliflozin in bulk drug and tablet dosage form Asian J. Pharm. Clin. Res. 2015 8 320 326 

  12. 12. Mallikarjuna Rao N. Gowri Sankar D. RP-HPLC method for simultaneous estimation and stability indicating study of metformin and linagliptin in pure and pharmaceutical dosage forms Int. J. Pharm. Pharm. Sci. 2015 7 191 197 

  13. 13. Gite S. Patravale V. Validation of RP-HPLC method and stress degradation for the combination of metformin HCl, atorvastatin calcium and glimepiride: Application to nanoparticles J. Chromatogr. Sci. 2015 53 1654 1662 10.1093/chromsci/bmv068 26071607 

  14. 14. Satheeshkumar N. Pradeepkumar M. Shanthikumar S. Rao V.J. Development of validated stability indicating assay method for simultaneous estimation of metformin hydrochloride and vildagliptin by RP-HPLC Drug Res. 2014 64 124 129 10.1055/s-0033-1354373 24081820 

  15. 15. Elrefay H. Ismaiel O.A. Hassan W.S. Shalaby A. Development and validation of a stability-indicating HPLC-UV method for the determination of pioglitazone hydrochloride and metformin hydrochloride in bulk drug and combined dosage form Asian J. Pharm. Clin. Res. 2013 6 Suppl. 4 116 120 

  16. 16. Raghava Raju T.V. Jagan Mohan T.S.S. Bhavani Prasad S.V.S.G. Suresh Kumar P. Someswara Rao N. Mrutyunjaya Rao I. Development, validation and resolving mass balance issue by using alternative oxidizing reagents for the determination of metformin hydrochloride impurities in API and pharmaceutical dosage forms Asian J. Pharm. Clin. Res. 2013 6 Suppl. 4 107 115 

  17. 17. Peraman R. Gowra C.S. Reddy Y.P. Peruru K.K. Stability-indicating RP-HPLC method for simultaneous determination of metformin hydrochloride and sitagliptin phosphate in dosage forms Chromatographia 2013 76 1153 1162 10.1007/s10337-013-2525-4 

  18. 18. Kavitha K.Y. Geetha G. Hariprasad R. Kaviarasu M. Venkatnarayanan R. Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of linagliptin and metformin in pure and pharmaceutical dosage form J. Chem. Pharm. Res. 2013 5 230 235 

  19. 19. Rank M. Kapupara P. Shah K. Development and validation of stability indicating HPTLC method for pioglitazone hydrochloride and metformin hydrochloride Res. J. Pharm. Technol. 2016 9 1555 1561 10.5958/0974-360X.2016.00305.X 

  20. 20. Srivani J. Umamahesh B. Veeresham C. Development and validation of stability indicating hptlc method for simultaneous determination of linagliptin and metformin Int. J. Pharm. Pharm. Sci. 2016 8 112 115 

  21. 21. Thakkar P.P. Patel N.R. Kothari C.S. Patel R. Mehta P.J. Validated stability indicating high performance thin layer chromatographic method for repaglinide API Indian Drugs 2015 52 48 54 

  22. 22. Akhtar J. Fareed S. Aqil M. Stability-indicating assay of repaglinide in bulk and optimized nanoemulsion by validated high performance thin layer chromatography technique J. Pharm. Bioallied Sci. 2013 5 184 190 24082694 

  23. 23. Jain P. Patel M. Surana S. Development and validation of stability-indicating high-performance thin-layer chromatography method for estimation of repaglinide in bulk and in pharmaceutical formulation Acta Chromatogr. 2013 25 531 544 10.1556/AChrom.25.2013.3.9 

  24. 24. Deshpande K. Ranaware P. Madgulkar A.R. DamLe M.C. Development and validation of stability indicating HPTLC method for determination of repaglinide Res. J. Pharm. Technol. 2013 6 158 161 

  25. 25. Xavier C.M. Basavaiah K. Development and validation of a simple stability indicating UPLC method for the determination of repaglinide in pharmaceuticals Thai J. Pharm. Sci. 2013 37 84 94 

  26. 26. Patel D.R. Patel L.J. Patel M.M. Development and validation of stability indicating method for the determination of repaglinide in pharmaceutical dosage form using high performance liquid chromatography Int. J. ChemTech Res. 2011 3 539 546 

  27. 27. Sharma M.C. Sharma S. Stability indicating RP-HPLC method for determination and validation of repaglinide in pharmaceutical dosage form Int. J. ChemTech Res. 2011 3 210 216 

  28. 28. Joshi S.S. Nahire R.R. Shastri N.R. Surendranath K.V. Satish J. Validated stability-indicating RP-HPLC UV method for simultaneous determination of metformin and repaglinide Acta Chromatogr. 2012 24 419 432 10.1556/AChrom.24.2012.3.6 

  29. 29. Sonia K. Nappinnai M. Manikandan K. Stability indicating RP-HPLC method for the estimation of metformin hydrochloride and repaglinide as API and estimation in tablet dosage form Int. J. Pharm. Qual. Assur. 2016 7 46 50 

  30. 30. Council of Europe European Pharmacopeia 9th ed. Council of Europe Strasbourg, France 2016 

  31. 31. Markiewicz M. Jungnickel C. Stolte S. Białk-Bieliska A. Kumirska J. Mrozik W. Primary degradation of antidiabetic drugs J. Hazard. Mater. 2017 324 428 435 10.1016/j.jhazmat.2016.11.008 27829515 

  32. 32. Wu Y. Levons J. Narang A.S. Raghavan K. Rao V.M. Reactive impurities in excipients: Profiling, identification and mitigation of drug-excipient incompatibility AAPS PharmSciTech. 2011 12 1248 1263 10.1208/s12249-011-9677-z 21948318 

  33. 33. Shah P.A. Shrivastav P.S. Shah J.V. George A. Simultaneous quantitation of metformin and dapagliflozin in human plasma by LC-MS/MS: Application to a pharmacokinetic study Biomed. Chromatogr. 2018 33 e4453 10.1002/bmc.4453 30517974 

  34. 34. Abbas Moussa B. Mahrouse M.A. Fawzy M.G. A validated LC-MS/MS method for simultaneous determination of linagliptin and metformin in spiked human plasma coupled with solid phase extraction: Application to a pharmacokinetic study in healthy volunteers J. Pharm. Biomed. Anal. 2019 163 153 161 10.1016/j.jpba.2018.09.052 30312887 

  35. 35. Quintao F.J.O. Freitas J.R.L. de Fatima Machado C. Aquino S.F. de Queiroz Silva S. de Cassia Franco Afonso J. Characterization of metformin by-products under photolysis, photocatalysis, ozonation and chlorination by high-performance liquid chromatography coupled to high-resolution mass spectrometry Rapid Commun. Mass Spectrom. 2016 30 2360 2368 10.1002/rcm.7724 27530893 

  36. 36. Sharma K. Pawar G. Yadam S. Giri S. Rajagopal S. Mullangi R. LC-MS/MS-ESI method for simulateneous quantitation of metformin and repaglinide in rat plasma and its application to pharmacokinetic study in rats Biomed. Chromatogr. 2013 27 356 364 22865648 

  37. 37. Kancherla P. Keesari S. Alevegete P. Khagga M. Das Parthasarathi, Identification, isolation and synthesis of seven novel impurities of anti-diabetic drug repaglinide Drug Test. Anal. 2018 10 212 221 10.1002/dta.2207 28421713 

  38. 38. Purna Chander C. Raju B. Ramesh M. Shankar G. Srinivas R. Liquid chromatography-electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products Rapid Commun. Mass Spectrom. 2018 32 1181 1190 10.1002/rcm.8151 29723439 

  39. 39. Balpande H.M. Raut N.S. Umekar M.J. Kotagale N.R. Compatibility study of metformin with pharmaceutical excipients Int. J. ChemTech Res. 2013 5 1684 1693 

  40. 40. Chowdary Y.A. Raparla R. Madhuri M. Formulation and evaluation of multilayered tablets of pioglitazone hydrochloride and metformin hydrochloride J. Pharm. 2014 2014 848243 10.1155/2014/848243 

  41. 41. Santos A. Basilio I. de Souza F. Medeiros A. Pinto M.F. de Santana D. Macedo R. Application of thermal analysis in study of binary mixtures with metformin J. Therm. Anal. Calorim. 2008 93 361 364 10.1007/s10973-007-7876-3 

  42. 42. Li J. Wu Y. Lubricants in pharmaceutical dosage forms Lubricants 2014 2 21 43 10.3390/lubricants2010021 

  43. 43. Ebrahimi H.A. Javadzadehl Y. Hamidi M. Jalali M.B. Repaglinide-loaded solid lipid nanoparticles: Effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles DARU J. Pharm. Sci. 2015 23 1 11 10.1186/s40199-015-0128-3 

  44. 44. Ceban I. Blajovan R. Vlase G. Albu P. Koppandi O. Vlase T. Thermoanalytical measurements conducted on repaglinide to estimate the kinetic triplet followed by compatibility studies between the antidiabetic agent and various experiments J. Therm. Anal. Calorim. 2016 126 195 204 10.1007/s10973-016-5729-7 

  45. 45. International Conference on Harmonization (ICH) Guidance for Industry Q1B: Photostability Testing of New Active Substances and Medicinal Products International Conference on Harmonization (ICH) Geneva, Switzerland 2006 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로